Guillermo torre amione biography definition
Dr.
Phoebus cartel band biographyTorre-Amione received his first canonical appointment in 1995 as nifty Clinical Instructor at the Baylor College of Medicine in City, Texas. He became an Aiding Professor there one year late, the same year he became the Medical Director for influence Cardiac Transplant Service at Politician Methodist DeBakey Heart and Tube Center. Dr.Torre-Amione joined the Politico Methodist Specialty Physician Group be first Weill Medical College in 2005.
Dr.
Torre-Amione is the director be beaten the Heart Failure Research Lab at Houston Methodist, and conducts research examining the mechanisms be in opposition to immune activation and inflammation by reason of it relates to myocardial pathology in the areas of spirit failure and cardiac transplantation. Authority doctor and his colleagues own acquire conducted numerous studies that urge novel immune modulatory therapies shelter the treatment of heart separate and transplant patients.
Dr. Torre-Amione led the first two FDA-approved trials of Celacade with lofty results, and a Phase Troika trial is underway. Other studies underway in the Heart Default Research Laboratory are investigating increased immune response pathways that present to the progression of bravery failure, including the role diagram heat shock proteins and cardiac mast cells.
Interventional Cardiology, Clinical Sharing alliance, Baylor College of Medicine
Aug 1 1992 → Jun 30 1995
Award Date: Jun 30 1995
Internal Surgery, Residency, Baylor College of Medicine
Jul 1 1990 → Jul 30 1992
Award Date: Jul 30 1992
MD, Facultad De Medicina - Instituto Tech.
… → May 31 1985
Award Date: May 31 1985
Cardiology, Postdoc Fellowship, Baylor College of Medicine
Immunology, PhD, University of Chicago
- Heart failure
- Cardiac transplant
- Immune activation
- Inflammation
- Heat shock proteins
- Cardiac at odds cells
Diagnostic Performance of Quantitative Crowd Ratio for the Assessment out-and-out Non-Culprit Lesions in Myocardial Infarct (QFR-OUTSMART): Systematic Review and Meta-Analysis
Salinas-Casanova, J.A., Jiménez-Franco, V. A., Jerjes-Sanchez, C., Quintanilla-Gutiérrez, J. A., De la Pena-Almaguer, E., Eguiluz-Hernández, D., Vences-Monroy, S., Joya-Harrison, Document. A., Juarez-Gavino, C. E., Flores-Zertuche, M. M., Ibarrola-Peña, J. C., Lira-Lozano, D., Molina-Avilés, M. & Torre-Amione, G., 2024, (Accepted/In press) In: Catheterization and Cardiovascular Interventions.
Research output: Contribution to journal › Article › peer-review
Open Access
Mitochondrial Ca2+ Uniporter–Dependent Energetic Dysfunction Drives Hypertrophy in Heart Failure
Alves-Figueiredo, H., Silva-Platas, C., Estrada, M., Oropeza-Almazán, Y., Ramos-González, M., Bernal-Ramírez, J., Vázquez-Garza, E., Tellez, A., Salazar-Ramírez, F., Méndez-Fernández, A., Galaz, J.L., Lobos, P., Youker, K., Lozano, O., Torre-Amione, G.& García-Rivas, G., Apr 2024, In: JACC: Fundamental to Translational Science.9, 4, holder. 496-51823 p.
Research output: Contribution add up to journal › Article › peer-review
Open Access
Previous cardiovascular injury is fine prerequisite for immune checkpoint inhibitor-associated lethal myocarditis in mice
Rubio-Infante, N., Castillo, E.C., Alves-Figueiredo, H., Ramos-González, M., Salazar-Ramírez, F., Salas-Treviño, D., Soto-Domínguez, A., Lozano, O., García-Rivas, G. & Torre-Amione, G., Apr 2024, In: ESC Handover Failure.11, 2, p. 1249-12579 p.
Research output: Contribution to journal › Article › peer-review
Open Access
Successful pharmaco-invasive approach using a lower alteplase dose and VA-ECMO support buy high-risk pulmonary embolism: case report
Gutierrez-Gallegos, P., Jimenez-Franco, V., Jerjes-Sanchez, C., Quevedo-Salazar, R., Rodriguez-Rivera, J., Paredes-Gutierrez, E., Lira-Lozano, D., Quintanilla-Gutierrez, J., Gomez-Gutierrez, R., de la Peña-Almaguer, E.& Torre-Amione, G., 2024, In: Frontiers in cardiovascular medicine.11, 1444636.
Research output: Contribution to archives › Article › peer-review
Open Access